Drug Profile

Gallium-68 NeoBOMB1 - Advanced Accelerator Applications

Alternative Names: 68Ga-NeoBOMB1; [68Ga]Ga-NeoB; Gallium NeoB

Latest Information Update: 29 Jul 2026

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Erasmus University Rotterdam; National Center for Scientific Research Demokritos
Developer Advanced Accelerator Applications; Erasmus University Rotterdam
Class Gallium radioisotopes; Imaging agents; Neuropeptides; Organometallic compounds; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
Mechanism of Action Bombesin receptor antagonists; Ionising radiation emitters; Neuropeptide receptor antagonists; Positron-emission tomography enhancers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

Yes - Gastrointestinal stromal tumours
New Molecular Entity No

Phase II Breast cancer
Phase I/II Gastrointestinal stromal tumours; HER2 negative breast cancer; Solid tumours
Phase I Glioblastoma
No development reported Colorectal cancer; Non-small cell lung cancer; Prostate cancer; Small cell lung cancer

29 Jul 2026 Efficacy, adverse events and pharmacokinetics data from a phase-I/II NeoRay trial in Solid tumours presented at the 62nd Annual Meeting of the American Society of Clinical Oncology (ASCO-2026)
27 Dec 2025 Advanced Accelerator Applications completes the Phase-I/II clinical trials in Solid tumours (Diagnosis) in USA, Austria, France, Netherlands, Spain and United Kingdom (IV) (NCT03872778)
10 May 2024 CTP Push 700361998 -KDM, DT, HE

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com